Skip to content

Effects of Pistacia atlantica oleoresin in treatment of functional dyspepsia

Comparison of efficacy of Pistacia atlantica L. oleoresin with that of placebo in treatment of patients with functional dyspepsia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20090804002288N14
Enrollment
100
Registered
2018-07-16
Start date
2018-09-23
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia. Functional dyspepsia

Interventions

Intervention 1: Intervention group: Pistacia atlantica oleoresin is administered to a group of 50 patients at the dose of two 200 mg capsules every 12 hours for 2 month. Intervention 2: Control group:

Sponsors

Iranian academic center for education culture and research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients aged 20 to 80 Patients with functional dyspepsia according to the ROME III criteria Patients without organic, systemic and metabolic diseases causing dyspepsia

Exclusion criteria

Exclusion criteria: Pregnant women Women planning pregnancy Breast-feeding women

Design outcomes

Primary

MeasureTime frame
Dyspepsia. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Hong Kong dyspepsia index questionnaire.

Secondary

MeasureTime frame
Quality of life. Timepoint: Before intervention and 2 months after intervention. Method of measurement: SF-36 questionnaire.;Helicobacter pylori infection. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Urease test.;Adverse drug reactions. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Patient questioning.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Saeed Kianbakht

Iranian academic center for education culture and research

kianbakht@imp.ac.ir+98 26 3476 4010

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026